JPWO2023105898A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023105898A5 JPWO2023105898A5 JP2023510304A JP2023510304A JPWO2023105898A5 JP WO2023105898 A5 JPWO2023105898 A5 JP WO2023105898A5 JP 2023510304 A JP2023510304 A JP 2023510304A JP 2023510304 A JP2023510304 A JP 2023510304A JP WO2023105898 A5 JPWO2023105898 A5 JP WO2023105898A5
- Authority
- JP
- Japan
- Prior art keywords
- antisense oligonucleotide
- complementary strand
- complex according
- length
- antisense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023200811A JP2024015491A (ja) | 2021-12-07 | 2023-11-28 | アンチセンスオリゴヌクレオチド複合体 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021198890 | 2021-12-07 | ||
| JP2021198890 | 2021-12-07 | ||
| PCT/JP2022/036699 WO2023105898A1 (ja) | 2021-12-07 | 2022-09-30 | アンチセンスオリゴヌクレオチド複合体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023200811A Division JP2024015491A (ja) | 2021-12-07 | 2023-11-28 | アンチセンスオリゴヌクレオチド複合体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2023105898A1 JPWO2023105898A1 (enExample) | 2023-06-15 |
| JPWO2023105898A5 true JPWO2023105898A5 (enExample) | 2023-11-09 |
| JP7412668B2 JP7412668B2 (ja) | 2024-01-15 |
Family
ID=86730115
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023510304A Active JP7412668B2 (ja) | 2021-12-07 | 2022-09-30 | アンチセンスオリゴヌクレオチド複合体 |
| JP2023200811A Pending JP2024015491A (ja) | 2021-12-07 | 2023-11-28 | アンチセンスオリゴヌクレオチド複合体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023200811A Pending JP2024015491A (ja) | 2021-12-07 | 2023-11-28 | アンチセンスオリゴヌクレオチド複合体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250297249A1 (enExample) |
| EP (1) | EP4446414A4 (enExample) |
| JP (2) | JP7412668B2 (enExample) |
| CN (1) | CN118660965A (enExample) |
| WO (1) | WO2023105898A1 (enExample) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013089283A1 (en) * | 2011-12-16 | 2013-06-20 | National University Corporation Tokyo Medical And Dental University | Chimeric double-stranded nucleic acid |
| AU2014272526A1 (en) * | 2013-05-30 | 2015-12-10 | National University Corporation Tokyo Medical And Dental University | Double-stranded agents for delivering therapeutic oligonucleotides |
| CA2915443A1 (en) * | 2013-06-16 | 2014-12-24 | National University Corporation Tokyo Medical And Dental University | Double-stranded antisense nucleic acid with exon-skipping effect |
| WO2016161388A1 (en) * | 2015-04-03 | 2016-10-06 | University Of Massachusetts | Fully stabilized asymmetric sirna |
| EP3571300A1 (en) * | 2017-01-19 | 2019-11-27 | ProQR Therapeutics II B.V. | Oligonucleotide complexes for use in rna editing |
| CN110799647A (zh) * | 2017-06-23 | 2020-02-14 | 马萨诸塞大学 | 双尾自递送sirna及相关的方法 |
| JP7333079B2 (ja) * | 2018-03-19 | 2023-08-24 | 国立大学法人 東京医科歯科大学 | 毒性が軽減した核酸 |
-
2022
- 2022-09-30 JP JP2023510304A patent/JP7412668B2/ja active Active
- 2022-09-30 WO PCT/JP2022/036699 patent/WO2023105898A1/ja not_active Ceased
- 2022-09-30 EP EP22903832.8A patent/EP4446414A4/en active Pending
- 2022-09-30 CN CN202280081447.9A patent/CN118660965A/zh active Pending
- 2022-09-30 US US18/717,295 patent/US20250297249A1/en active Pending
-
2023
- 2023-11-28 JP JP2023200811A patent/JP2024015491A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113994000B (zh) | 包括胞苷类似物的反义rna编辑寡核苷酸 | |
| CN114514318B (zh) | 寡核苷酸和靶rna的位点特异性编辑方法 | |
| JP2019214587A5 (enExample) | ||
| JP2021101709A5 (enExample) | ||
| JP2014527401A5 (enExample) | ||
| JP2017535552A5 (enExample) | ||
| Goodchild | Therapeutic oligonucleotides | |
| JP2009514877A5 (enExample) | ||
| JP2017093448A5 (enExample) | ||
| JP2018516091A5 (enExample) | ||
| JP2010525813A5 (enExample) | ||
| JP2013511990A5 (enExample) | ||
| JP2007529224A5 (enExample) | ||
| JP2005517432A5 (enExample) | ||
| WO2007051045A3 (en) | Compositions and methods for inhibiting expression of huntingtin gene | |
| US20110055965A1 (en) | Cycle single-stranded nucleic acid complex and method for producing the same | |
| JP7033591B2 (ja) | 治療用オリゴヌクレオチドの捕捉および検出 | |
| WO2010006973A3 (en) | Compositions and methods for inhibiting expression of tgf-beta receptor genes | |
| JP2021505129A5 (enExample) | ||
| RU2014121304A (ru) | Ингибирование экспрессии вирусных генов | |
| Sabat et al. | Template-dependent DNA ligation for the synthesis of modified oligonucleotides | |
| WO2006117400A3 (en) | Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors | |
| CN121079412A (zh) | 经修饰的指导rna | |
| JPWO2023105898A5 (enExample) | ||
| WO2023167276A1 (ja) | キャップ化ｒｎａ及びその製造方法並びにタンパク質の製造装置及びタンパク質の製造方法 |